Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ATACAR: Pravastatin and Spironolactone for Anthracycline-Induced Cardiomyopathy
NCT04190433Phase 2Withdrawn
- Sponsor
- Mayo Clinic
- Start
- Sep 2020
- Primary completion
- Apr 2023
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of pravastatin, spironolactone in anthracycline-induced cardiomyopathy (AIC), sponsored by Mayo Clinic. Planned start Sep 2020; status: withdrawn.
02
Drugs
pravastatinspironolactone
03
Conditions
anthracycline-induced cardiomyopathy (AIC)
Beyond the preview
Go deeper on NCT04190433.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04190433.